July 11, 2023
Peter Fedichev, co-founder and CEO of Gero, is a relative newcomer to the field of geroscience with a background in physics and not in biology. However, Peter has firmly established himself and Gero in the longevity landscape by twice publishing in Nature, entering a lucrative collaboration with Pfizer, and proposing a new aging-related theory. We...
July 08, 2022
Vadim Gladyshev is a Professor of Medicine at Brigham and Women's Hospital and Harvard Medical School, and he is one of the most prominent figures in geroscience today. We discussed various competing hypotheses on the nature of aging, the lack of the unified theory of aging and the need for one, and several fascinating papers...